Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

The peptide GHK-Cu helps heal and remodel tissue, improves skin and hair health, and has potential for treating age-related inflammatory diseases.

Finasteride helps hair growth but stopping it causes faster hair loss.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Lasers in hair transplantation show promise but are not yet standard, with current methods causing some side effects and needles still being preferred for creating recipient sites.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

A new acne cream effectively reduced acne in trials and awaits FDA approval.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Apremilast shows promise for several skin conditions but needs more research.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

There are many treatments for common hair loss, but more trials are needed to decide which are best.